Clinical Trial Update: Janus Feasibility Study [NA]

View source ↗

Summary

A feasibility study (NCT03985527) sponsored by Respicardia for sleep apnea syndromes has completed; the snippet provides status but does not include efficacy re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sleep Apnea

Snippet

Sponsor: Respicardia, Inc. | Conditions: Sleep Apnea Syndromes | NA | Status: COMPLETED